Hemodynamic Effects of Aerosolized Iloprost in Pulmonary Hypertension at Rest and During Exercise
Authors:
- Friedrich C. BlumbergFBFriedrich C. Blumberg
- Günter A. J. RieggerGRGünter A. J. Riegger
- Michael PfeiferMPMichael Pfeifer
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin AnalogueNew England Journal of Medicine, 2000
- Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled TrialAnnals of Internal Medicine, 2000
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Pulmonary artery hemodynamics in primary pulmonary hypertensionJACC, 1993
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992
- Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease?Circulation, 1986
- Hemodynamic Effects of Nifedipine at Rest and during Exercise in Primary Pulmonary HypertensionChest, 1984
- Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.Circulation, 1982